Esomeprazole magnesium (Nexium)

ApprovedCompleted
0 views this week 0 watching Active
Interest: 43/100
43
Hype Score

Development Stage

Pre-clinical
Phase 1
Phase 2
Phase 3
5
Approved
Indication / Disease

Heartburn

Conditions

Heartburn

Trial Timeline

Nov 1, 2004 → Jul 1, 2005

About Esomeprazole magnesium (Nexium)

Esomeprazole magnesium (Nexium) is a approved stage product being developed by AstraZeneca for Heartburn. The current trial status is completed. This product is registered under clinical trial identifier NCT00206024. Target conditions include Heartburn.

What happened to similar drugs?

6 of 14 similar drugs in Heartburn were approved

Approved (6) Terminated (0) Active (8)

Hype Score Breakdown

Clinical
20
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (2)

NCT IDPhaseStatus
NCT00206024ApprovedCompleted
NCT00079833Phase 3Completed